Cytonus Therapeutics

About:

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Website: https://cytonus.com/

Twitter/X: cytonustx

Top Investors: National Institutes of Health, Creative Ventures, Wilson Sonsini Goodrich & Rosati, Partners Investment, John Ballantyne

Description:

Cytonus Therapeutics is a biotech company combining AI-driven drug discovery with a Cargocyte, a synthetic biology approach towards drug-delivery. Cytonus is on a mission to treat immune related disorders with precision delivery and in vivo production of first in class therapeutics.

Total Funding Amount:

$20.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2018-01-01

Founders:

Remo Moomiaie-Qajar M.D., Richard Klemke, PhD.

Number of Employees:

11-50

Last Funding Date:

2023-11-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai